Key facts
- Post Acute Analytics’s last known valuation is $178.0M (Jul 2025).
- It has raised $67.9M across 3 recorded rounds; the latest was Early Stage VC ($43.1M) in Mar 2022.
- Notable investors include Warburg Pincus, Rubicon Founders, Concord Health Partners, Dorilton Capital, Dorilton Ventures — 6 tracked in total.
- Post Acute Analytics has filed 4 Form Ds with the SEC since 2018, most recently Jul 2025 ($43.1M sold to 14 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Post Acute Analytics
Funding rounds
3 roundsAbout Post Acute Analytics
Operator of a real-time tracking platform intended to improve patient lives by acting on insights across a connected healthcare system. The company's platform offers automated data capture to digest structured and unstructured data with no duplicative data entry and selective binding technology for real-time data that connects to the continuum of care and integrates with all major acute and post-acute electronic medical records, enabling healthcare providers to provide total transparency to their patient's journeys through post-acute care.
- Sector
- Healthcare
- HQ
- Irving, TX, United States
- Founded
- 2014
- Employees
- 79
- Website
- paanalytics.com/
- Ownership
- Privately Held (backing)
Post Acute Analytics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Post Acute Analytics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Post Acute Analytics in its N-PORT filings yet. We sweep new filings monthly.